These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 33282948)

  • 1. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
    Yang Q; Yu B; Sun J
    Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
    Liu J; Wan Y; Li S; Qiu H; Jiang Y; Ma X; Zhou S; Cheng W
    Cancer Med; 2020 May; 9(10):3522-3536. PubMed ID: 32170852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
    Lei X; Zhang M; Guan B; Chen Q; Dong Z; Wang C
    Hum Genomics; 2021 Jun; 15(1):39. PubMed ID: 34187556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
    Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
    Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes That Predict Poor Prognosis in Breast Cancer via Bioinformatical Analysis.
    Zhou Q; Liu X; Lv M; Sun E; Lu X; Lu C
    Biomed Res Int; 2021; 2021():6649660. PubMed ID: 33959662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer via Integrated Bioinformatical Analysis.
    Wei J; Wang Y; Shi K; Wang Y
    Biomed Res Int; 2020; 2020():8959210. PubMed ID: 32258155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer.
    Yang Y; Sheng Y; Zheng J; Ma A; Chen S; Lin J; Yang X; Liang Y; Zhang Y; Zheng X
    Biomarkers; 2024 Jun; 29(4):185-193. PubMed ID: 38568742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CENPE, PRC1, TTK, and PLK4 May Play Crucial Roles in the Osteosarcoma Progression.
    Wang F; Zhao Q; Liu W; Kong D
    Technol Cancer Res Treat; 2020; 19():1533033820973278. PubMed ID: 33176597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
    Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
    J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.